Hasil Pencarian - David Yeung

  • Menampilkan 1 - 13 hasil dari 13
Perbaiki Hasil
  1. 1
    Editorial: Advances in the treatment of chronic myeloid leukemia

    Editorial: Advances in the treatment of chronic myeloid leukemia oleh Ahmet Emre Eşkazan, Chung H. Kok, Chung H. Kok, Chung H. Kok, David Yeung, David Yeung, David Yeung, David Yeung, Jignesh Dalal, Jignesh Dalal, Mario Tiribelli, Mario Tiribelli

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Reversible Neonatal Cholestasis Following In Utero Exposure to Valproic Acid

    Reversible Neonatal Cholestasis Following In Utero Exposure to Valproic Acid oleh Douglas G Chang, Martin Stein, David Sine, David Yeung, Frank Mannino

    Diterbitkan 2020-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia

    Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia oleh Ville-Petteri Mäkinen, Jacqueline Rehn, James Breen, David Yeung, Deborah L. White

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA

    S151: COMBINATION OF LARGE SPLEEN AND LOW IN VIVO KINASE INHIBITION IS AN EARLY PREDICTOR OF INFERIOR MOLECULAR RESPONSE AND POOR OUTCOMES IN CHRONIC MYELOID LEUKAEMIA oleh Chung Kok, Verity Saunders, Phuong Dang, Naranie Shanmuganathan, Deborah White, Susan Branford, David Yeung, Timothy Hughes

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib

    Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib oleh Chung H. Kok, Verity A. Saunders, Phuong Dang, Naranie Shanmuganathan, Deborah White, Susan Branford, David Yeung, Timothy P. Hughes

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol

    A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol oleh Justin Lee, Nhu Tram Nguyen, James Wright, Ka-Kit David Yeung, Stephen Sagar, Do-Hoon Kim, Orest Ostapiak, Lilian Doerwald-Munoz, Timothy Whelan

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    P823: Insights and strategies for inclusive adolescent and young adult participation in genetics research

    P823: Insights and strategies for inclusive adolescent and young adult participation in genetics research oleh Tasha Wainstein, Courtney Cook, Daniel Assamad, Julia Heaton, Manraj Randhawa, David Yeung, Lauren Jennings, Robin Hayeems, Harpreet Chhina, Anthony Cooper, GenCOUNSEL. Study, Jehannine Austin, Alison Elliott

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH- B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL08 STUDY

    P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH- B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL... oleh Shaun Fleming, John Reynolds, Ashish Bajel, Nicola Venn, John Kwan, John Moore, David Yeung, Nalini Pati, Michael Leahy, Sushma Kollipara, Emma Verner, Leanne Berkahn, Rosemary Sutton, Andrew Wei, Matthew Greenwood

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    White matter integrity in young medication-naïve bipolar II depressed adults

    White matter integrity in young medication-naïve bipolar II depressed adults oleh Arthur Dun Ping Mak, Owen Ngo Wang Leung, Idy Wing Yi Chou, Sheila Lok Yiu Wong, Winnie Chiu-wing Chu, David Yeung, Suzanne Ho-wai So, Suk Ling Ma, Linda Chiu Wah Lam, Chi Ming Leung, Sing Lee

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Consumer engagement in health care policy, research and services: A systematic review and meta-analysis of methods and effects.

    Consumer engagement in health care policy, research and services: A systematic review and meta-analysis of methods and effects. oleh Louise K Wiles, Debra Kay, Julie A Luker, Anthea Worley, Jane Austin, Allan Ball, Alan Bevan, Michael Cousins, Sarah Dalton, Ellie Hodges, Lidia Horvat, Ellen Kerrins, Julie Marker, Michele McKinnon, Penelope McMillan, Maria Alejandra Pinero de Plaza, Judy Smith, David Yeung, Susan L Hillier

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

    The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia oleh Lucy C. Fox, Katherine D. Cummins, Ben Costello, David Yeung, Rebecca Cleary, Cecily Forsyth, Maciek Tatarczuch, Kate Burbury, Olga Motorna, Jake Shortt, Shaun Fleming, Andrew McQuillan, Anthony Schwarer, Rosemary Harrup, Amy Holmes, Sumita Ratnasingam, Kah-Lok Chan, Wei-Hsun Hsu, Asma Ashraf, Faye Putt, Andrew Grigg

    Diterbitkan 2017-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways

    De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways oleh Vera Magistroni, Mario Mauri, Deborah D’Aliberti, Caterina Mezzatesta, Ilaria Crespiatico, Miriam Nava, Diletta Fontana, Nitesh Sharma, Wendy Parker, Andreas Schreiber, David Yeung, Alessandra Pirola, Sara Readelli, Luca Massimino, Paul Wang, Praveen Khandelwal, Stefania Citterio, Michela Viltadi, Silvia Bombelli, Roberta Rigolio, Roberto Perego, Jacqueline Boultwood, Alessandro Morotti, Giuseppe Saglio, Dong-Wook Kim, Susan Branford, Carlo Gambacorti-Passerini, Rocco Piazza

    Diterbitkan 2019-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials?

    How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? oleh Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: